Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
In what ways do lipitor's generic prices vary across formulary tiers?Does generic lipitor's cost reduction outweigh potential drawbacks?What is the current stage of apotex's ruxolitinib generic development in the us?How long's the wait for live vaccines post cosentyx?What's the mechanism of lipitor in inhibiting protein for cholesterol?
See the DrugPatentWatch profile for valtoco
Efficacy and Safety of Valtoco in Seniors Valtoco, also known as diazepam for intranasal use, is a medication used to treat acute seizures, including those associated with epilepsy. Seniors are more susceptible to adverse effects due to age-related changes in metabolism and pharmacokinetics. Age-Related Risks and Interactions Research suggests that older adults may experience increased sensitivity to benzodiazepines, such as diazepam, which can lead to adverse effects like sedation, confusion, and impaired cognitive function [1]. This is because aging affects the way the body processes and eliminates medications, potentially increasing their concentrations and potentiating their effects. Furthermore, seniors often take multiple medications concurrently, which can increase the risk of adverse interactions and drug-drug interactions [2]. As diazepam is metabolized by the cytochrome P450 enzyme system, concurrent use with other medications that inhibit or induce this system can affect Valtoco's efficacy and safety profile [3]. Patient Concerns and Monitoring Seniors and their caregivers should be aware of potential side effects, such as: * Sedation and drowsiness * Confusion and disorientation * Falls and injuries * Impaired cognitive function * Allergic reactions or anaphylaxis Regular monitoring of Valtoco's effectiveness, side effects, and potential interactions will help ensure safe and effective treatment in seniors. Patent and Exclusivity Valtoco, marketed by Epirium Therapeutics, has an exclusivity period that began in 2020 [4]. As exclusivity expires, generic and biosimilar versions of diazepam for intranasal use may become available, potentially offering more affordable alternatives. Comparison with Other Treatments For seniors, alternative seizure treatments may include other benzodiazepines, anticonvulsants, or newer medications with improved safety profiles [5]. It's essential to discuss individual suitability with a healthcare professional, weighing potential benefits and risks. Additional Resources For further information, consult DrugPatentWatch.com for the latest patent and exclusivity status for Valtoco [6]. References [1] 'Medicare.gov. (n.d.). Prescription Drug Plans. [Internet] Retrieved from https://www.medicare.gov/pharmaceuticals/coverage/prescription-drug-plans/ [2] 'The Merck Manual. (n.d.). Medication Use in Older Adults. [Internet] Retrieved from https://www.merckmanuals.com/professional/geriatrics/medication-prodiction-geriatric-population/medication-use-in-older-adults [3] 'National Institute on Aging. (n.d.). Medicines and Older People. [Internet] Retrieved from: https://www.nia.nih.gov/health/medicines-and-older-people [4] 'DrugPatentWatch.com. (2022). Valtoco. [Internet] Retrieved from: https://www.drugpatentwatch.com/drug/valtoco/ [5] 'Epilepsy Foundation. (n.d.). Medications. [Internet] Retrieved from: https://www.epilepsy.com/learn/treatment/medications [6] 'DrugPatentWatch.com. [Internet] Retrieved from https://www.drugpatentwatch.com/
Other Questions About Valtoco :